Richard Patricio

President and CEO of Mega Uranium Ltd., a uranium-focused investment and development company with assets in Canada and  Australia. He is a qualified lawyer (Ontario) with over 15 years of experience working with and for public companies. He  has built a number of mining companies with global operations and spent 10 years with a TSX-listed investment company focused in the early-stage investment space. Mr. Patricio holds and has held senior officer and director positions in  several companies that are listed on the TSX, ASX, NYSE and AIM exchanges. Mr. Patricio received his law degree from  Osgoode Hall and was called to the Ontario bar in 2000.

A behavioural pharmacologist with extensive experience in facilitating the discovery and development of novel CNS drugs. He has co-founded, held executive level positions and consulted for Life Science  companies including CanCog Technologies, Vivocore, Karyopharm Therapeutics, NPM Pharma, Ketogen, and Epione Animal Health. He did his graduate training in pharmacology at the  University of Toronto and has done extensive research examining psychoactive drugs.

More than 20 years of finance industry experience. His diverse experience includes roles as C-Suite Executive, as a sell-side research analyst, in fund management, managing director of investment banking and sits on the Board of several public companies in Canada